Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2024-05-17

FDA Approved: ANASTROZOLE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

The FDA approved Teva's supplemental application for Anastrozole (generic), resulting in updated labeling for this product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Anastrozole (Anastrozole)

Snippet

SUPPL AP for ANASTROZOLE (ANASTROZOLE)